
Multiple myeloma is a rare blood malignancy that affects the plasma cells. Plasma cells are white blood cells that form part of your immune system. Plasma cells (also known as B-cells) produce antibodies. Immunoglobulins, or antibodies, aid in the fight against infection.
Multiple myeloma develops when healthy cells become abnormal and multiply, producing abnormal antibodies known as M proteins. This alteration triggers a chain reaction of medical problems and illnesses that can harm your bones, kidneys, and body's capacity to produce healthy white and red blood cells and platelets.
Early in multiple myeloma, there may be no symptoms. When signs and symptoms occur, they may include:
Cancer staging provides the foundation for treatment. The staging approach for multiple myeloma begins by classifying the condition into one of four categories:
Causes
Healthcare practitioners and researchers are unsure what causes multiple myeloma. Some probable causes they're looking into include:
Risk Factors
The following factors may raise the risk of multiple myeloma:
Complications
The complications of multiple myeloma include:
Some preventative tips for multiple myeloma:
These strategies can help manage risk factors and encourage early detection.
Treatments may include:
Targeted therapy: Therapy with a specific goal in mind. Targeted therapy employs medications that target specific molecules in cancer cells. Targeted medications that block these molecules can kill cancer cells.
Cost Start From USD 2000 - USD 10000Explore Options
Immunotherapy: Immunotherapy is a medicine-based treatment that stimulates the immune system to attack cancer cells.
Cost Start From USD 15000 - USD 50000Explore Options
CAR-T cell therapy: Chimeric antigen receptor T cell treatment, also known as CAR-T cell therapy, prepares your immune system cells to combat multiple myeloma. This treatment starts by removing some white blood cells, especially T cells, from your blood. The cells are transferred to a laboratory. In the lab, cells are treated to produce specific receptors. The receptors aid cells recognise a marker on the surface of myeloma cells.
Cost Start From USD 75000 - USD 125000Explore Options
Chemotherapy: It is a treatment that uses strong medications to kill cancer cells. The medicines kill rapidly growing cells, including myeloma cells.
Cost Start From USD 1500 - USD 3500Explore Options
Bone marrow transplants: A bone marrow transplant, also known as a stem cell transplant, involves replacing damaged bone marrow with healthy bone marrow.
Radiation therapy: Radiation therapy uses high-energy beams to attack cancer cells. Energy can be derived from X-rays, protons, or other sources.
The following tests and procedures diagnose multiple myeloma:
Multiple myeloma rehabilitation focuses on enhancing quality of life, symptom management, and physical and mental recovery. Here are some main rehab options:
MediGence can assist and guide you in selecting the best physician and medical facility for your care.
Depending on the circumstances, your doctor may prescribe medication to assist you in managing your symptoms and support your treatment plan.
Treatment regimens are adapted to the patient's specific cancer stage and location.









Kuala Lumpur, Malaysia
Sunway Medical Centre has initiated a comprehensive expansion plan close to its current hospital facility to enhance its ability to provide services to the global market. The new Cancer Radiosurgery Center and Nuclear Medicine Center, which will also house additional Centers of Excellence like the Digestive Health Center and Dialysis Center, marked the completion of Tower C's first phase in October 2016.

Kuala Lumpur, Malaysia
Prince Court is a private medical facility in the center of Kuala Lumpur that has 277 individual beds. Our dedication is to provide you with the best treatment possible from the time you arrive until you depart, healthier and happier. We are well-known for our top-notch facilities, cutting-edge technology, and friendly customer service.

Kuala Lumpur, Malaysia
Subang Jaya Medical Center is renowned for pioneering radiation oncology treatments and infrastructure in Malaysia. The hospital also has a state-of-the-art Cancer Radiosurgery Centre (CRC), which is fully furnished with the latest medical technology for cancer detection, monitoring, and treatment.
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
Here are some of the reasons for choosing Malaysia:
In Malaysia, a bone marrow transplant, sometimes referred to as a stem cell transplant, is a viable therapy option for multiple myeloma.
Depending on the patient's condition, both autologous and allogeneic stem cell transplants are available at renowned hospitals nationwide.
Highly skilled oncologists and haematologists perform these treatments, utilising state-of-the-art equipment to maximise patient outcomes.
The stage of the disease determines the prognosis for multiple myeloma in Malaysia, as well as the patient's general condition and response to treatment.
Advanced treatment options include immunotherapy, chemotherapy, and stem cell transplants help many patients by improving their quality of life and extending remissions.
Disease management in Malaysia is enhanced by early diagnosis and customized treatment options.
To improve treatment, Malaysia participates in numerous myeloma clinical trials, including Phase 3 studies on novel treatments like teclistamab and pomalidomide. It also contributes to sizable regional research networks.
Treating multiple myeloma during pregnancy requires a careful, individualised approach, as many standard treatments are contraindicated. In such circumstances, doctors would closely evaluate the mother's and baby's health and consider the safest treatment alternatives during pregnancy.
Immunotherapy is a promising treatment option for multiple myeloma. In Malaysia, immune checkpoint inhibitors and monoclonal antibodies assist the immune system in targeting and destroying malignant cells.
In Malaysia, multiple myeloma (MM) survival rates differ depending on the disease's stage and the availability of treatment. With one-year and two-year overall survival rates of 82% and 70%, respectively, a study from a tertiary referral centre in Malaysia revealed a median overall survival that was not met. Additionally, this study discovered that improved progression-free survival (PFS) and OS were linked to maintenance medication and the lack of renal impairment. These differences demonstrate how patient demographics, treatment regimens, and early identification affect MM survival rates.
In Malaysia, autologous stem cell transplants (ASCT) employ the patient's cells, whereas allogeneic stem cell transplants use donor cells. Both procedures are available in specialised centres for the treatment of multiple myeloma.
Yes, advanced multiple myeloma can still be treated with immunotherapy, targeted treatments, and stem cell transplantation. Palliative treatment is also available to alleviate symptoms and improve quality of life.